11
Total investments
2
Early stage
3
Mid stage
3
Late stage
8y
Years active
Portfolio
10 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Oct 2025
Based on a heritage of defense, security and technology innovation, Kraus Hamdani Aerospace Inc. is disrupting the UAS space by developing cost-effective fully electric zero-emissions AI powered unmanned aircraft that fly with infinite airborne endurance.
Our UAS are a world first for truly persistent aerial capabilities to revolutionize how we conduct non-stop airborne services. We mimic nature by utilizing onboard AI to silently glide through the air like a bird, and generate clean onboard energy using power harvested from the sun. Our technology is a breakthrough for modern aviation and autonomous robotics and can be adapted to revolutionize how we build the airplanes of tomorrow.
Investor
Mar 2025
Phoenix Tailings is pioneering the future of clean mining and metals production.
We are dedicated to building the world’s first fully clean mining and refining company, producing the critical metals needed for the next generation of technology and infrastructure. By harvesting valuable materials directly from mining tailings, we eliminate waste streams while creating a sustainable and domestic supply of rare earths and other essential resources.
We are already commercially shipping rare earth metals and alloys to magnet customers today, proving both the scalability and impact of our approach. Our breakthrough refining model provides a clean and reliable supply chain, empowering industries from defense and aerospace to electric vehicles, renewable energy, and medical technologies.
Phoenix Tailings has been commercially shipping rare earth metal products since 2023, demonstrating our leadership in bringing sustainable solutions to market.
Investor - Acquired by Apple
Oct 2023
Betteromics is a GenAI-powered, secure, collaborative, cloud-based DevOps-as-a-Service (DaaS) platform that accelerates innovation for life science companies. By seamlessly integrating cutting-edge science, streamlined processes, untamed data, and the power of generative AI, Betteromics empowers organizations to extract valuable insights from massive amounts of multimodal data across the entire drug lifecycle. Real-time insights and advanced signal detection, driven by GenAI, facilitate data-driven decision-making, enabling scientists and researchers to develop personalized medicine faster and more efficiently.
Investor
Jun 2021
We are a human-centered robotics company. Our mission is to make technical advances towards robots and humans working together side by side, with an emphasis on human-centric design. Diligent Robotics is developing a suite of artificial intelligence that enables robots to collaborate with and adapt to humans in everyday environments.
Our service robots are designed to participate and work together with teams of humans. Our first product is a hospital service robot that can assist clinical staff with logistical tasks, allowing them to spend more of their time on direct patient care, improving patient satisfaction, quality of service, and safety.
Investor and Advisor
May 2020
Biobot Analytics develops cutting-edge technology to transform sewers into public health observatories. Wastewater contains valuable information about the health of communities. We collect it. We analyze it. We tell you how to leverage it to make your city better.
Our first product is to measure opioids and other drug metabolites in sewage to estimate consumption in cities. With this data, those working on harm reduction can assess the scope of the epidemic, allocate resources, and gauge the effectiveness of programming over time.
Investor and Advisor
Mar 2019
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
Investor and Advisor
Jun 2018
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company’s ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth’s deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.
Investor & Advisor
Jun 2018
KETOS is a vertically integrated water intelligence platform with intelligent hardware, bi-directional connectivity infrastructure, interactive software, and hassle-free services, all for a predictable, flat service fee.
Were transforming how water operators measure, manage, and forecast water quality and efficiency in industrial, agricultural, and municipal applications.
KETOS combines hardware, software, connectivity, automated reporting, predictive analytics, and maintenance to automate water monitoring and testing as a fully integrated platform. Our goal is to provide water operators with the visibility to identify and solve mission-critical water efficiency and water quality challenges (in real-time or before they happen). Equipped with up-to-the-minute data and predictive algorithms, operators can now ensure their water meets specific quality and safety standards.
KETOS can monitor water for 30+ parameters, including:
- Environmental factors (Total Dissolved Solids, Temperature, Conductivity, Salinity, pH, Oxidation Reduction Potential [ORP], Dissolved Oxygen)
- Inorganics (Alkalinity, Dissolved Boron, Dissolved Silica, Free Chlorine, Residual Chlorine, Total Hardness)
- Heavy metals (Chromium, Copper, Iron, Lead, Manganese, Zinc, Selenium, Mercury, Arsenic, Cadmium, Calcium)
- Nutrients (Orthophosphates, Nitrates)
Investor and Advisor
Mar 2018
Einride is an industry-disrupting freight technology company providing end-to-end solutions for electric and autonomous shipping.
By deploying technologies that are integrated using its data-driven operating system, Saga, it enables customers to decarbonize their operations by making an immediate shift towards digitalized, electric road freight.
In 2019, Einride became the world’s first company to operate an autonomous, electric freight vehicle on a public road. Its vision is to make Earth a better place through intelligent movement.
Experience · 13 entries
All (13)
Investments (11)
Founder (1)
2025
Investor
Oct 2025
Based on a heritage of defense, security and technology innovation, Kraus Hamdani Aerospace Inc. is disrupting the UAS space by developing cost-effective fully electric zero-emissions AI powered unmanned aircraft that fly with infinite airborne endurance.
Our UAS are a world first for truly persistent aerial capabilities to revolutionize how we conduct non-stop airborne services. We mimic nature by utilizing onboard AI to silently glide through the air like a bird, and generate clean onboard energy using power harvested from the sun. Our technology is a breakthrough for modern aviation and autonomous robotics and can be adapted to revolutionize how we build the airplanes of tomorrow.
Investor
Mar 2025
Phoenix Tailings is pioneering the future of clean mining and metals production.
We are dedicated to building the world’s first fully clean mining and refining company, producing the critical metals needed for the next generation of technology and infrastructure. By harvesting valuable materials directly from mining tailings, we eliminate waste streams while creating a sustainable and domestic supply of rare earths and other essential resources.
We are already commercially shipping rare earth metals and alloys to magnet customers today, proving both the scalability and impact of our approach. Our breakthrough refining model provides a clean and reliable supply chain, empowering industries from defense and aerospace to electric vehicles, renewable energy, and medical technologies.
Phoenix Tailings has been commercially shipping rare earth metal products since 2023, demonstrating our leadership in bringing sustainable solutions to market.
2024
FORBES 2024: 50 / 50 Investment
Jul 2024
Forbes Media is a global media, branding and technology company, with a focus on news and information about business, investing, technology, entrepreneurship, leadership and affluent lifestyles. The company publishes Forbes, Forbes Asia, and Forbes Europe magazines as well as Forbes.com. The Forbes brand today reaches more than 94 million people worldwide with its business message each month through its magazines and 37 licensed local editions around the globe, Forbes.com, TV, conferences, research, social and mobile platforms. Forbes Media’s brand extensions include conferences, real estate, education, financial services, and technology license agreements.
Forbes is an equal opportunity employer.
2023
Investor - Acquired by Apple
Oct 2023
Betteromics is a GenAI-powered, secure, collaborative, cloud-based DevOps-as-a-Service (DaaS) platform that accelerates innovation for life science companies. By seamlessly integrating cutting-edge science, streamlined processes, untamed data, and the power of generative AI, Betteromics empowers organizations to extract valuable insights from massive amounts of multimodal data across the entire drug lifecycle. Real-time insights and advanced signal detection, driven by GenAI, facilitate data-driven decision-making, enabling scientists and researchers to develop personalized medicine faster and more efficiently.
Show all 13 entries ↓
Investment activity
2018–2025 · 11 investments
Recent (last 2 years)Earlier
